Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report.

Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, Mamadu I, Akinpelu A, Ahmad A, Burga J, Ndoreraho A, Nkunzimana E, Manneh L, Mohammed A, Adeoye O, Tom-Aba D, Silenou B, Ipadeola O, Saleh M, Adeyemo A, Nwadiutor I, Aworabhi N, Uke P, John D, Wakama P, Reynolds M, Mauldin MR, Doty J, Wilkins K, Musa J, Khalakdina A, Adedeji A, Mba N, Ojo O, Krause G, Ihekweazu C; CDC Monkeypox Outbreak Team.

Lancet Infect Dis. 2019 Jul 5. pii: S1473-3099(19)30294-4. doi: 10.1016/S1473-3099(19)30294-4. [Epub ahead of print]

PMID:
31285143
2.

Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma.

Dallmayer M, Li J, Ohmura S, Alba Rubio R, Baldauf MC, Hölting TLB, Musa J, Knott MML, Stein S, Cidre-Aranaz F, Wehweck FS, Romero-Pérez L, Gerke JS, Orth MF, Marchetto A, Kirchner T, Bach H, Sannino G, Grünewald TGP.

Cell Death Dis. 2019 Feb 11;10(2):116. doi: 10.1038/s41419-019-1372-0.

3.

Incidence and risk factors for pre-eclampsia in Jos Nigeria.

Musa J, Mohammed C, Ocheke A, Kahansim M, Pam V, Daru P.

Afr Health Sci. 2018 Sep;18(3):584-595. doi: 10.4314/ahs.v18i3.16.

4.

Mycotoxins in poultry feed and feed ingredients in Nigeria.

Akinmusire OO, El-Yuguda AD, Musa JA, Oyedele OA, Sulyok M, Somorin YM, Ezekiel CN, Krska R.

Mycotoxin Res. 2019 May;35(2):149-155. doi: 10.1007/s12550-018-0337-y. Epub 2018 Nov 27.

5.

Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.

Musa J, Achenbach CJ, Evans CT, Jordan N, Daru PH, Hou L, Murphy RL, Adewole IF, Simon MA.

BMC Health Serv Res. 2018 Nov 22;18(1):885. doi: 10.1186/s12913-018-3700-y.

6.

Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.

Orth MF, Gerke JS, Knösel T, Altendorf-Hofmann A, Musa J, Alba-Rubio R, Stein S, Hölting TLB, Cidre-Aranaz F, Romero-Pérez L, Dallmayer M, Baldauf MC, Marchetto A, Sannino G, Knott MML, Wehweck F, Ohmura S, Li J, Hakozaki M, Kirchner T, Dandekar T, Butt E, Grünewald TGP.

Int J Cancer. 2019 Feb 15;144(4):859-867. doi: 10.1002/ijc.31903. Epub 2018 Dec 4.

PMID:
30267407
7.

Hepatitis B virus large surface protein is priming for hepatocellular carcinoma development via induction of cytokinesis failure.

Musa J, Li J, Grünewald TG.

J Pathol. 2019 Jan;247(1):6-8. doi: 10.1002/path.5169. Epub 2018 Nov 16.

PMID:
30246253
8.

Systematic identification of cancer-specific MHC-binding peptides with RAVEN.

Baldauf MC, Gerke JS, Kirschner A, Blaeschke F, Effenberger M, Schober K, Rubio RA, Kanaseki T, Kiran MM, Dallmayer M, Musa J, Akpolat N, Akatli AN, Rosman FC, Özen Ö, Sugita S, Hasegawa T, Sugimura H, Baumhoer D, Knott MML, Sannino G, Marchetto A, Li J, Busch DH, Feuchtinger T, Ohmura S, Orth MF, Thiel U, Kirchner T, Grünewald TGP.

Oncoimmunology. 2018 Jul 23;7(9):e1481558. doi: 10.1080/2162402X.2018.1481558. eCollection 2018.

9.

Phytoestrogen supplementation and body composition in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials.

Glisic M, Kastrati N, Musa J, Milic J, Asllanaj E, Portilla Fernandez E, Nano J, Ochoa Rosales C, Amiri M, Kraja B, Bano A, Bramer WM, Roks AJM, Danser AHJ, Franco OH, Muka T.

Maturitas. 2018 Sep;115:74-83. doi: 10.1016/j.maturitas.2018.06.012. Epub 2018 Jun 22. Review.

PMID:
30049351
10.

The Need for Societal Investment to Improve Cervical Cancer Outcomes in Nigeria: A commentary.

Musa J.

Afr J Reprod Health. 2017 Dec;21(4):17-23. doi: 10.29063/ajrh2017/v21i4.2.

PMID:
29624947
11.

The association between gut microbiome, sex, age and body condition scores of horses in Maiduguri and its environs.

Mshelia ES, Adamu L, Wakil Y, Turaki UA, Gulani IA, Musa J.

Microb Pathog. 2018 May;118:81-86. doi: 10.1016/j.micpath.2018.03.018. Epub 2018 Mar 9.

PMID:
29530806
12.

miRNA-Processing Gene Methylation and Cancer Risk.

Joyce BT, Zheng Y, Zhang Z, Liu L, Kocherginsky M, Murphy R, Achenbach CJ, Musa J, Wehbe F, Just A, Shen J, Vokonas P, Schwartz J, Baccarelli AA, Hou L.

Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):550-557. doi: 10.1158/1055-9965.EPI-17-0849. Epub 2018 Feb 23.

13.

Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets.

Baldauf MC, Orth MF, Dallmayer M, Marchetto A, Gerke JS, Rubio RA, Kiran MM, Musa J, Knott MML, Ohmura S, Li J, Akpolat N, Akatli AN, Özen Ö, Dirksen U, Hartmann W, de Alava E, Baumhoer D, Sannino G, Kirchner T, Grünewald TGP.

Oncotarget. 2017 Aug 4;9(2):1587-1601. doi: 10.18632/oncotarget.20098. eCollection 2018 Jan 5.

14.

PRC1: Linking Cytokinesis, Chromosomal Instability, and Cancer Evolution.

Li J, Dallmayer M, Kirchner T, Musa J, Grünewald TGP.

Trends Cancer. 2018 Jan;4(1):59-73. doi: 10.1016/j.trecan.2017.11.002. Epub 2017 Dec 16. Review.

PMID:
29413422
15.

Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature.

Silas OA, Achenbach CJ, Murphy RL, Hou L, Sagay SA, Banwat E, Adoga AA, Musa J, French DD.

Expert Rev Vaccines. 2018 Jan;17(1):91-98. doi: 10.1080/14760584.2018.1411195. Epub 2017 Dec 6. Review.

PMID:
29183182
16.

Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.

Musa J, Achenbach CJ, O'Dwyer LC, Evans CT, McHugh M, Hou L, Simon MA, Murphy RL, Jordan N.

PLoS One. 2017 Sep 5;12(9):e0183924. doi: 10.1371/journal.pone.0183924. eCollection 2017. Review. Erratum in: PLoS One. 2017 Dec 29;12 (12 ):e0190661.

17.

Erratum to: Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.

Silas OA, Achenbach CJ, Hou L, Murphy RL, Egesie JO, Sagay SA, Agbaji OO, Agaba PA, Musa J, Manasseh AN, Jatau ED, Dauda AM, Akanbi MO, Mandong BM.

Infect Agent Cancer. 2017 Jun 26;12:37. doi: 10.1186/s13027-017-0149-2. eCollection 2017.

18.

MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.

Musa J, Aynaud MM, Mirabeau O, Delattre O, Grünewald TG.

Cell Death Dis. 2017 Jun 22;8(6):e2895. doi: 10.1038/cddis.2017.244. Review.

19.

Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.

Silas OA, Achenbach CJ, Hou L, Murphy RL, Egesie JO, Sagay SA, Agbaji OO, Agaba PE, Musa J, Manasseh AN, Jatau ED, Dauda AM, Akanbi MO, Mandong BM.

Infect Agent Cancer. 2017 Jun 5;12:34. doi: 10.1186/s13027-017-0144-7. eCollection 2017. Erratum in: Infect Agent Cancer. 2017 Jun 26;12 :37.

20.

Molecular detection of Nigerian field isolates of Mycoplasma mycoides subsp. mycoides as causative agents of contagious bovine pleuropneumonia.

Musa JA, O O Bale J, Kazeem HM, Nwankpa ND, Di Provvido A, Sacchini F, Zilli K, Abass A, Scacchia M, Pini A.

Int J Vet Sci Med. 2016 Dec 10;4(2):46-53. doi: 10.1016/j.ijvsm.2016.10.007. eCollection 2016 Dec.

21.

TOBACCO ABUSE AND ITS HEALTH EFFECT.

Dunga JA, Adamu Y, Kida IM, Alasiya D, Jibrin Y, Sabo U, Ukoli C, Chuhwak CH, Musa JJ.

Niger J Med. 2015 Oct-Dec;24(4):354-62. Review.

PMID:
27487614
22.

Can Sierra Leone maintain the equitable delivery of their Free Health Care Initiative? The case for more contextualised interventions: results of a cross-sectional survey.

Vallières F, Cassidy EL, McAuliffe E, Gilmore B, Bangura AS, Musa J.

BMC Health Serv Res. 2016 Jul 13;16:258. doi: 10.1186/s12913-016-1496-1.

23.

FEV1, FVC, FEV1 /FVVC as predictors of rhinitis among saw mill workers in north central Nigeria.

Dunga JA, Alkali NH, Adamu YM, Bathna S, Suleiman Y, Ukoli C, Musa JJ.

Niger J Med. 2016 Apr-Jun;25(2):152-8.

PMID:
29944313
24.

Cervical cancer survival in a resource-limited setting-North Central Nigeria.

Musa J, Nankat J, Achenbach CJ, Shambe IH, Taiwo BO, Mandong B, Daru PH, Murphy RL, Sagay AS.

Infect Agent Cancer. 2016 Mar 24;11:15. doi: 10.1186/s13027-016-0062-0. eCollection 2016.

25.

Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.

Musa J, Orth MF, Dallmayer M, Baldauf M, Pardo C, Rotblat B, Kirchner T, Leprivier G, Grünewald TG.

Oncogene. 2016 Sep 8;35(36):4675-88. doi: 10.1038/onc.2015.515. Epub 2016 Feb 1. Review.

PMID:
26829052
26.

Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.

Mitchell KM, Lépine A, Terris-Prestholt F, Torpey K, Khamofu H, Folayan MO, Musa J, Anenih J, Sagay AS, Alhassan E, Idoko J, Vickerman P.

AIDS. 2015 Sep 24;29(15):2035-44. doi: 10.1097/QAD.0000000000000798.

27.

Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central Nigeria.

Sagay AS, Ebonyi AO, Meloni ST, Musa J, Oguche S, Ekwempu CC, Oyebode T, Ejeliogu E, Imade GE, Agbaji OO, Okonkwo P, Kanki PJ.

Curr HIV Res. 2015;13(3):193-200.

PMID:
25986370
28.

Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria.

Agbaji OO, Abah IO, Falang KD, Ebonyi AO, Musa J, Ugoagwu P, Agaba PA, Sagay AS, Jolayemi T, Okonkwo P, Idoko JA, Kanki PJ.

Curr HIV Res. 2015;13(3):184-92.

PMID:
25986369
29.

High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology.

Musa J, Achenbach C, Taiwo B, Berzins B, Silas O, Daru PH, Agbaji O, Imade G, Sagay AS, Idoko JA, Kanki PJ, Murphy RL.

Infect Agent Cancer. 2014 Nov 3;9(1):36. doi: 10.1186/1750-9378-9-36. eCollection 2014.

30.

BODY WEIGHT CHANGES IN WOMEN USING IMPLANON IN JOS, NIGERIA.

Pam VC, Musa J, Mutihir JT, Karshima JA, Anyaka CU, Sagay AS.

Afr J Med Med Sci. 2014 Sep;43(Suppl):15-21.

31.

DECLINING PREVALENCE OF HIV AND OTHER SEXUALLY TRANSMITTED INFECTIONS AMONG FEMALE SEX WORKERS IN JOS, NORTH-CENTRAL NIGERIA.

Ogbe AE, Sagay AS, Imade GE, Musa J, Pam VC, Egah D, Onwuliri V, Short R.

Afr J Med Med Sci. 2014 Sep;43(Suppl 1):5-13.

32.

Association of Bacterial vaginosis and other Sexually Transmitted Infections with HIV among pregnant women in Nigeria.

Imade GE, Musa J, Sagay AS, Kapiga SH, Sankale JL, Idoko J, Kanki P.

Afr J Med Med Sci. 2014 Sep;43(Suppl 1):23-28.

33.

Clinical Utility of Pharmacy-Based Adherence Measurement in Predicting Virologic Outcomes in an Adult HIV-Infected Cohort in Jos, North Central Nigeria.

Abah IO, Ojeh VB, Musa J, Ugoagwu P, Agaba PA, Agbaji O, Okonkwo P.

J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):77-83. doi: 10.1177/2325957414539197. Epub 2014 Jun 24.

PMID:
24963086
34.

Knowledge, attitude and practices on malaria among the rural communities in aliero, northern Nigeria.

Singh R, Musa J, Singh S, Ebere UV.

J Family Med Prim Care. 2014 Jan;3(1):39-44. doi: 10.4103/2249-4863.130271.

35.

Declining rate of infection with maternal human immunodeficiency virus at delivery units in north-central Nigeria.

Imade GE, Sagay AS, Musa J, Ocheke AN, Adeniyi DS, Idighri M, Powl R, Sendeht A, Ogwuche JP, Elujoba M, Egbodo CO, Oyebode T, Daru PH, Agbaji O, Pam IC, Meloni ST, Okonkwo P, Kanki PJ.

Afr J Reprod Health. 2013 Dec;17(4 Spec No):138-45.

PMID:
24689325
36.

Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria.

Imade GE, Sagay AS, Chaplin B, Chebu P, Musa J, Okpokwu J, Hamel DJ, Pam IC, Agbaji O, Samuels J, Meloni S, Sankale JL, Okonkwo P, Kanki P.

AIDS Res Hum Retroviruses. 2014 Feb;30(2):127-33. doi: 10.1089/AID.2013.0074. Epub 2013 Nov 22.

37.

High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.

Musa J, Taiwo B, Achenbach C, Olugbenga S, Berzins B, Sagay AS, Idoko JA, Kanki PJ, Murphy RL.

Arch Gynecol Obstet. 2013 Dec;288(6):1365-70. doi: 10.1007/s00404-013-2885-x. Epub 2013 May 23.

PMID:
23700253
38.

Knowledge of HIV prevention and willingness to collaborate in vaginal microbicides trials-survey of Nigerian gynecologists.

Musa J, Adamu IS, Muhammad Z, Egbodo C, Mohammed C.

Niger J Med. 2012 Apr-Jun;21(2):185-9.

PMID:
23311188
39.
40.

Non-intubated Ambulatory Anaesthesia for Diagnostic gynaecological laparoscopy.

Isamade E, Agbo D, Sagay A, Musa J, Egbodo C, Agbo D.

J West Afr Coll Surg. 2013 Jan;3(1):14-24.

41.

Prevalence and associated risk factors for gestational diabetes in Jos, North-central, Nigeria.

Anzaku AS, Musa J.

Arch Gynecol Obstet. 2013 May;287(5):859-63. doi: 10.1007/s00404-012-2649-z. Epub 2012 Dec 6.

PMID:
23224650
42.
43.

Hydatidiform mole in Jos, Nigeria.

Ocheke AN, Musa J, Uamai AO.

Niger Med J. 2011 Oct;52(4):223-6. doi: 10.4103/0300-1652.93792.

44.

Substance abuse among antenatal patients at jos university teaching hospital, north central Nigeria.

Mutihir J, Musa J, Daru P, Nyango D, Audu M.

J West Afr Coll Surg. 2012 Apr;2(2):50-62.

45.

Generating evidence for surgical practice in Africa: the role of clinical research.

Musa J.

Afr J Paediatr Surg. 2012 Jan-Apr;9(1):62-5. doi: 10.4103/0189-6725.93310. No abstract available.

47.

Underutilization of vaginal hysterectomy and its impact on residency training.

Ocheke AN, Ekwempu CC, Musa J.

West Afr J Med. 2009 Sep-Oct;28(5):323-6.

PMID:
20383838
48.

Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes.

Musa J, Taiwo B, Goldsmith S, Sutton S, Berzins B, Murphy RL.

Arch Gynecol Obstet. 2011 Feb;283(2):343-8. doi: 10.1007/s00404-010-1421-5. Epub 2010 Mar 14.

PMID:
20229315
49.

Ectopic pregnancy in Jos Northern Nigeria: prevalence and impact on subsequent fertility.

Musa J, Daru PH, Mutihir JT, Ujah IA.

Niger J Med. 2009 Jan-Mar;18(1):35-8.

PMID:
19485145
50.

Genital tract abnormalities among female sex workers who douche with lemon/lime juice in Nigeria.

Sagay AS, Imade GE, Onwuliri V, Egah DZ, Grigg MJ, Musa J, Thacher TD, Adisa JO, Potts M, Short RV.

Afr J Reprod Health. 2009 Mar;13(1):37-45.

PMID:
20687264

Supplemental Content

Support Center